J&J to buy cardio technology company Abiomed for $16.6B

Oct 31, 2022, 3:51 PM | Updated: Nov 1, 2022, 7:06 am
FILE - The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock E...

FILE - The Johnson & Johnson logo appears above a trading post on the floor of the New York Stock Exchange, Monday, July 12, 2021. Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed, Tuesday, Nov. 1, 2022, and build up its medical device division. The health care giant says it will pay $380 for each Biomed share and also provide another $35 per share in cash if some commercial and clinical milestones are met. Abiomed provides technology that treats coronary artery disease and heart failure. (AP Photo/Richard Drew, file)

(AP Photo/Richard Drew, file)

Johnson & Johnson is spending more than $16 billion to move deeper into treating heart disease and continue a shift started last year away from its consumer health roots.

The health care giant said Tuesday that it will buy the cardiovascular technology company Abiomed, which makes a heart pump used on patients with severe coronary artery disease.

The deal is expected to close early next year and will bolster J&J’s MedTech or medical device division. That’s one of two remaining segments, along with pharmaceuticals, that the company is focused on after announcing that it would split off its consumer health division that sells Band Aids and beauty products.

The deal for Danvers, Massachusetts-based Abiomed will complement J&J’s existing heart business and comes with “significant” expansion opportunities, CEO Joaquin Duato told analysts during a Tuesday morning conference call.

It also adds to J&J’s portfolio a company with explosive growth. Abiomed sales jumped 22% to exceed $1 billion in its most recent fiscal year. That is well over twice the annual sales it booked just five years ago.

J&J’s BioSense business focuses on treating arrhythmia or an irregular heartbeat. Abiomed will add, among other products, its Impella heart pumps, which are inserted through arteries into the hearts of high-risk patients. They temporarily help the heart maintain blood flow while a surgeon places stents in the patient.

Abiomed will run as a stand-alone business within J&J’s medical device segment once the deal is completed.

J&J said it will pay $380 in cash for each Abiomed share. It also will throw in another $35 per share in cash if some commercial and clinical milestones are met in a few years.

J&J will pay for the deal with a combination of cash and short-term financing. The company expects the acquisition to be neutral or to slightly dilute adjusted earnings in the first year after its completion. It then expects that the deal will help its bottom line starting in 2024.

The deal comes a few weeks after J&J said it topped third-quarter expectations, thanks to growth from its largest segment, pharmaceuticals. Sales climbed 2% in the company’s medical device segment, to $6.78 billion.

Shares of Johnson & Johnson, based in New Brunswick, New Jersey, slipped nearly a dollar to $173.11 in Tuesday morning trading. The Dow Jones Industrial Average, of which J&J is a component, rose slightly.

Shares of Abiomed Inc. soared more than 50% to $380.

___

Follow Tom Murphy on Twitter: https://twitter.com/thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

arrest...
Associated Press

Police: Washington officer shot, wounded while making arrest

Pasco Police in southeast Washington state said one of their officers was shot and wounded Thursday afternoon while making an arrest.
16 hours ago
State hospital...
Associated Press

7 die from flu in Washington state, activity ‘very high’

Flu activity in the state is now considered very high, according to the Washington State Department of Health.
16 hours ago
Associated Press

Guest lineups for the Sunday news shows

WASHINGTON (AP) — ABC’s “This Week” — Reps. Hakeem Jeffries, D-N.Y., and Dave Joyce, R-Ohio; Sam Bankman-Fried, founder and former CEO of cryptocurrency exchange FTX. __ NBC’s “Meet the Press” — Israeli Prime Minister-designate Benjamin Netanyahu; Rep. Katherine Clark, D-Mass. __ CBS’ “Face the Nation” — Secretary of State Antony Blinken; Reps. Pete Aguilar, D-Calif., […]
16 hours ago
Rev. Paula Stecker of the Christ the King Lutheran Church tidies up a memorial outside Club Q follo...
Associated Press

EXPLAINER: What do we know about the Colorado bomb threat?

DENVER (AP) — More than a year before police say Anderson Lee Aldrich killed five people and wounded 17 others at a gay night club in Colorado Springs, Aldrich was arrested on allegations of making a bomb threat that led to the evacuation of about 10 homes. Aldrich, who uses the pronoun they and is […]
16 hours ago
Pennsylvania state House of Representatives' impeachment managers Reps. Craig Williams, left, Tim B...
Associated Press

Philly prosecutor sues to stop lawmakers from removing him

HARRISBURG, Pa. (AP) — Philadelphia’s elected prosecutor asked a state court Friday to halt a Republican-led effort to remove him from office, arguing that the process ended when the Legislature’s two-year session ran out earlier in the week. District Attorney Larry Krasner, a Democrat, wants Commonwealth Court to declare that the General Assembly lacks constitutional […]
16 hours ago
Associated Press

Guilty plea in boy’s death that sparked federal task force

KANSAS CITY, Mo. (AP) — A man pleaded guilty Friday in the killing of a 4-year-old Kansas City boy whose death led to a federal operation meant to reduce violent crime in 2020. Ryson Ellis, 24, of Kansas City, was sentenced to 22 years in prison after pleading guilty to second-degree murder, unlawful use of […]
16 hours ago

Sponsored Articles

Comcast Ready for Business Fund...
Ilona Lohrey | President and CEO, GSBA

GSBA is closing the disparity gap with Ready for Business Fund

GSBA, Comcast, and other partners are working to address disparities in access to financial resources with the Ready for Business fund.
SHIBA WA...

Medicare open enrollment is here and SHIBA can help!

The SHIBA program – part of the Office of the Insurance Commissioner – is ready to help with your Medicare open enrollment decisions.
Lake Washington Windows...

Choosing Best Windows for Your Home

Lake Washington Windows and Doors is a local window dealer offering the exclusive Leak Armor installation.
Anacortes Christmas Tree...

Come one, come all! Food, Drink, and Coastal Christmas – Anacortes has it all!

Come celebrate Anacortes’ 11th annual Bier on the Pier! Bier on the Pier takes place on October 7th and 8th and features local ciders, food trucks and live music - not to mention the beautiful views of the Guemes Channel and backdrop of downtown Anacortes.
Swedish Cyberknife Treatment...

The revolutionary treatment of Swedish CyberKnife provides better quality of life for majority of patients

There are a wide variety of treatments options available for men with prostate cancer. One of the most technologically advanced treatment options in the Pacific Northwest is Stereotactic Body Radiation Therapy using the CyberKnife platform at Swedish Medical Center.
Work at Zum Services...

Seattle Public Schools announces three-year contract with Zum

Seattle Public Schools just announced a three-year contract with a brand-new company to the Pacific Northwest to assist with their student transportation: Zum.
J&J to buy cardio technology company Abiomed for $16.6B